Company: SNY
Filing Date: 2025-02-13
Form Type: 20-F
Source: 0001121404-25-000010
Chunk: 243

Company: Sanofi
Filing Date: 2025-02-13
Form: 20-F
Chunk 243
---
 out above, no TSR allocation can be made if Sanofi’s ranking is below median TSR, defined as the performance of the company ranked seventh in the panel. • The CSR criterion accounts for 10% of the award. This performance condition equates to the attainment over a three-year period of annual objectives plus a "stretch" objective, linked to the following pillars of Sanofi’s CSR strategy: 1. Affordable Access: providing essential medicines to non-communicable disease patients through Sanofi Global Health; 2. Planet Care: Carbon Footprint Reduction, scopes 1 & 2 (% reduction in CO 2 emissions vs 2019). Attainment of each annual CSR objective will earn one performance point; a maximum of three points, plus one extra point linked to the "stretch" objective, can be earned for each CSR pillar. For each criterion, attainment of the objectives for 2026 will earn three points even if the annual objectives were not attained. At the end of the period, the Board of Directors will determine the CSR Allocation Rate, corresponding to the number of points earned, as shown, below:

| CSR points earned  | CSR Allocation Rate |
| Less than 3 points | 0%                  |
| 3 points           | 50%                 |
| 4 points           | 67%                 |
| 5 points           | 83%                 |
| 6 points           | 100%                |
| 7 points           | 110%                |
| 8 points           | 120%                |

• The R&D pipeline criterion, accounting for 10% of the award, was introduced in 2024 to reflect the importance of Sanofi's commitment to developing a robust R&D pipeline. The performance criterion is based on the attainment levels of two equally- weighted performance indicators measured over a three-year period.

| 142 | SANOFIFORM 20-F2024 |

| PART I                                             |
| ITEM 6. Directors, Senior Management and Employees |

1. Clinical Trial Readouts (CTRs) - the number of clinical trial results based on forecast pipeline deliveries At the end of the period, the CTR attainment level will be calculated on the basis of the number of CTRs achieved in the period as follows:

| Number of Clinical Trial Readouts (CTRs) | CTR Attainment Level  |
| CTR < 15                                 | 0%                    |
| CTR = 15                                 | 50%                   |
| CTR > 15,